Why U.S. Stocks Are Trading Mixed; Labor Costs Increase Higher-Than-Expected In Q2
U.S. stocks traded mixed this morning, with the Nasdaq dropping around 90 points on Tuesday.
Verona Pharma’s Lung Disease Candidate Cuts COPD Exacerbations By 42%
Verona Pharma plc (NASDAQ:VRNA) has announced topline results from Phase 3 ENHANCE-2 of nebulized ensifentrine for the maintenance treatment of chronic…
Why Is BIMI International Medical Higher By Around 70%: Here Are 38 Stocks Moving Premarket
Gainers
BIMI International Medical Inc. (NASDAQ: BIMI) shares rose 69.6% to $1.04 in pre-market trading after Fnu Oudom reported a stake of 44% in the company in 13D.
Verona Pharma To Announce Top-Line Data From Phase 3 ENHANCE-2 Trial Of Nebulized Ensifentrine For COPD
Verona Pharma plc (NASDAQ:VRNA) ("Verona Pharma" or the "Company"), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that it will report top-line Phase 3 data from
Twitter Shares Surge Around 8%, Here’s 66 Biggest Movers From Yesterday
Gainers
Qurate Retail, Inc. (NASDAQ: QRTEB) shares climbed 71.1% to close at $5.20. Qurate Retail will host a conference call to discuss Q2 results on Friday, August 5th.
Wedbush Maintains Outperform on Verona Pharma, Lowers Price Target to $18
Wedbush analyst Liana Moussatos maintains Verona Pharma (NASDAQ:VRNA) with a Outperform and lowers the price target from $25 to $18.
44 Stocks Moving In Friday’s Mid-Day Session
Gainers
Cogent Biosciences, Inc. (NASDAQ: COGT) shares jumped 77% to $8.79 after the company reported initial data from its ongoing Phase 2 APEX clinical trial.
Recap: Verona Pharma Q1 Earnings
Verona Pharma (NASDAQ:VRNA) reported its Q1 earnings results on Tuesday, May 3, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.
Earnings Scheduled For May 3, 2022
Companies Reporting Before The Bell
• Kiniksa Pharmaceuticals (NASDAQ:KNSA) is projected to report earnings for its first quarter.